Frontlight ResearchEarly access
Ovarian cancer trials in United States
348 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 1Taking peopleTalazoparib and Radiation Therapy in Treating Patients With Locally Recurrent Gynecologic Cancers
- Where
- Baltimore, Houston
- Age
- 18 years and over
- People
- 24
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT03968406 - Phase 2Taking peopleTart Cherry Juice as a Dietary Supplement for the Prevention of Paclitaxel-Induced Neuropathy
- Where
- Sacramento
- Age
- 18 years and over
- People
- 86
- Run by
- University of California, Davis
See details and how to joinNCT06268665 - Phase 2Taking peopleRiluzole For Preventing Cognitive Dysfunction in Ca Pts Receiving Chemo (REFOCUS): Pilot Trial
- Where
- Orange
- Age
- 18 years and over
- People
- 24
- Run by
- University of California, Irvine
See details and how to joinNCT07447050 - No phaseTaking peopleWellSpan-THRIVE Cancer QOL Study
- Where
- Chambersburg, Ephrata, Gettysburg, Lebanon, York
- Age
- 18 years and over
- People
- 1,000
- Run by
- WellSpan Health
See details and how to joinNCT07433660 - No phaseTaking peopleWith Love, Grandma ("Con Cariño, Abuelita") Pilot Study
- Where
- Miami
- Age
- 21 years and over
- People
- 60
- Run by
- University of Miami Sylvester Comprehensive Cancer Center
See details and how to joinNCT05721976 - No phaseTaking peopleExercise as a Preventive Agent to Combat Immobility in Patients With Ovarian or Endometrial Cancers Receiving Chemotherapy
- Where
- Boston
- Age
- 18 years and over
- People
- 30
- Run by
- Dana-Farber Cancer Institute
See details and how to joinNCT04997096 - Phase 1Taking peopleFirst in Human Study of TORL-1-23 in Participants With Advanced Cancer
- Where
- Cleveland, Fairfax, Fullerton, Lexington, Los Angeles, Minneapolis, New York, Rochester, Tyler
- Age
- 18 years and over
- People
- 90 worldwide
- Run by
- TORL Biotherapeutics, LLC
See details and how to joinNCT05103683 - Phase 1Taking peopleA Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
- Where
- Baltimore, Chicago, Dallas, Durham, Hackensack, Houston, Lexington, Los Angeles, Miami, Nashville, New York, Philadelphia, Sacramento, San Francisco, Scottsdale, Seattle, Tucson
- Age
- 18 years and over
- People
- 90
- Run by
- Clasp Therapeutics, Inc.
See details and how to joinNCT06778863 - Phase 1Taking peopleA Study to Learn if 27T51, a Mucin-16 (MUC16) Protein Targeting Immune Cell Therapy, Administered Alone or in Combination is Safe and How Well it Works for Adult Participants With Recurrent or Treatment Resistant Ovarian Cancers
- Where
- Boston, Buffalo, Hackensack, Pittsburgh, Salt Lake City
- Age
- 18 years and over
- People
- 90
- Run by
- Regeneron Pharmaceuticals
See details and how to joinNCT06469281 - No phaseTaking peopleUltrasound Microvessel Imaging for the Evaluation of Ovarian and Adnexal Lesions
- Where
- Rochester
- Age
- 18 years and over
- People
- 40
- Run by
- Mayo Clinic
See details and how to joinNCT07280312 - No phaseEnrolling by invitationStrategy for Management of Patients With Hereditary Cancer Syndromes (HCS) in a Rural Environment
- Where
- Burlington
- Age
- 18 years and over
- People
- 200
- Run by
- University of Vermont Medical Center
See details and how to joinNCT07381985 - Phase 2Taking peopleTelmisartan in Combination With Cytotoxic Regimens in Platinum-Resistant Ovarian Cancer
- Where
- Lebanon, Manchester
- Age
- 18 years and over
- People
- 33
- Run by
- Tyler J Curiel
See details and how to joinNCT06815497 - No phaseTaking peopleSample Collection for Ongoing Research and Product Evaluation Study
- Where
- Austin
- Age
- 18 years and over
- People
- 9,600
- Run by
- Natera, Inc.
See details and how to joinNCT07318051 - Phase 1Taking peopleA Study of CUSP06 in Patients With Platinum-Refractory/Resistant Ovarian Cancer and Other Advanced Solid Tumors
- Where
- Boston, Denver, Fairfax, Grand Rapids, Houston, Miami Beach, Nashville, New Haven, New York, Oklahoma City, San Antonio, Sarasota
- Age
- 18 years and over
- People
- 263 worldwide
- Run by
- OnCusp Therapeutics, Inc.
See details and how to joinNCT06234423 · EU 2024-519862-33-01 - Phase 1Taking peopleA Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
- Where
- Austin, Dallas, Denver, Fairfax, Greenville, Huntersville, Oklahoma City, Orlando, San Antonio, Sarasota
- Age
- 18 years and over
- People
- 96
- Run by
- Dren Bio
See details and how to joinNCT06999187 - No phaseTaking peopleAn Automated Personalized Physical Activity Intervention to Improve Immune Function and Clinical Outcomes in Stage II-IV Ovarian, Primary Peritoneal or Fallopian Tube Cancer and Newly Diagnosed Endometrial Cancer, Life on the Go 3 Study
- Where
- Buffalo
- Age
- 18 years and over
- People
- 120
- Run by
- Roswell Park Cancer Institute
See details and how to joinNCT06855706 - Phase 2Taking peopleCATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.
- Where
- Annapolis, Atlanta, Boston, Chicago, Columbus, Doylestown, Duarte, Durham, Fort Worth, Fullerton, Jacksonville, Los Angeles, Minneapolis, New Brunswick, New Haven, Norfolk, Oklahoma City, Palo Alto, Philadelphia, Phoenix, Portland, Rochester, Santa Barbara, St Louis, Tucson
- Age
- 18 years and over
- People
- 230 worldwide
- Run by
- TORL Biotherapeutics, LLC
See details and how to joinNCT06690775 · EU 2024-517190-24-00 - Phase 2Taking peopleAutophagy Maintenance (AUTOMAIN)
- Where
- Charleston
- Age
- 18 years and over
- People
- 38
- Run by
- Medical University of South Carolina
See details and how to joinNCT06971744 - Phase 1/2Taking peopleA Study of MT-4561 in Patients With Various Advanced Solid Tumors
- Where
- Columbus, Grand Rapids, Houston, Los Angeles
- Age
- 18 years and over
- People
- 27 worldwide
- Run by
- Tanabe Pharma America, Inc.
See details and how to joinNCT06943521 - No phaseTaking peopleTransvaginal Ultrasonography as a Screening Method for Ovarian Cancer
- Where
- Lexington
- Age
- 24 years and over
- People
- 65,000
- Run by
- John R van Nagell
See details and how to joinNCT04473833 - Phase 2Taking peopleBelzutifan in Recurrent Clear Cell Carcinoma of Gynecologic Origin
- Where
- Boston
- Age
- 18 years and over
- People
- 32
- Run by
- Dana-Farber Cancer Institute
See details and how to joinNCT06677190 - Phase 1/2Taking peopleA Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer
- Where
- Ann Arbor, Aurora, Baltimore, Cincinnati, Evanston, Grand Rapids, Houston, Indianapolis, Los Angeles, Milwaukee, New Haven, Newport Beach, New York, Providence
- Age
- 18 years and over
- People
- 200
- Run by
- Volastra Therapeutics, Inc.
See details and how to joinNCT05902988 - No phaseEnrolling by invitationGenetic Education in BRCA Families
- Where
- Boston, Danville, Washington D.C.
- Age
- 21 years to 75 years
- People
- 240
- Run by
- Georgetown University
See details and how to joinNCT03544983 - No phaseTaking peopleSYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Where
- Albuquerque, Ann Arbor, Atlanta, Aurora, Baltimore, Bethesda, Billings, Birmingham, Boise, Buffalo, Chapel Hill, Charlottesville, Chicago, Cincinnati, Columbus, Dallas, Denver, Duarte, Duluth, Fargo, Greenville, Hartford, Hattiesburg, Hempstead, Houston, Iowa City, Irvine, Jacksonville, Kansas City, La Jolla, Lansing, Little Rock, Littleton, Manhasset, Mayfield Heights, Memphis, Miami, Milwaukee, Mobile, Morgantown, Nashville, Newark, New Brunswick, New Orleans, New York, Norwalk, Omaha, Orange, Philadelphia, Portland, Providence, Salt Lake City, San Francisco, Savannah, Scarborough, Scottsdale, Seattle, Silver Spring, Stanford, Staten Island, St Louis, Tampa, Temple, Towson, Tulsa, Winston-Salem, Worcester
- People
- 50,000 worldwide
- Run by
- Massive Bio, Inc.
See details and how to joinNCT03452774 - Phase 2Taking peopleA Phase 2 Study of Avutometinib (VS-6766) Plus Defactinib
- Where
- Albuquerque, New Orleans, Oklahoma City, Orlando
- Age
- 18 years to 99 years
- People
- 55
- Run by
- University of Oklahoma
See details and how to joinNCT05512208